Overall rank by patents
#40,284
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Flexuspine Inc.
USPTO PatentsView assignee record - 6 granted patents across 2 technology areas, active 2015–2022. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
6
Total patents granted
2
CPC technology areas
28.3
Avg claims per patent
-80%
5-year filing velocity
The verdict
Flexuspine holds 6 US patents across 2 technology areas, rank #40,284 of 50,000 tracked assignees.
- #40,284
- of 50,000 US assignees by volume
- Top 56%
- by Innovation Score (33.4/100)
- 28.3
- avg claims per patent
- -80%
- filing velocity, last 5 yrs
Portfolio overview
Flexuspine Inc. has been granted 6 US utility patents between 2015 and 2022, placing Flexuspine Inc. at rank #40,284 across all assignees tracked by PlainPatent. This portfolio spans 2 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.3 claims per patent with primary concentration in A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). As a US Corporation, Flexuspine Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Flexuspine sits between Fleetwood Group, Inc. (6 patents, rank #40,280) and Floway, Inc. (6 patents, rank #40,288) - the closest US assignees by grant volume. The composite Innovation Score of 33.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 5 in the 2015–2019 window, a -80% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Flexuspine Inc.'s 28.3 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while specialization in 2 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Flexuspine Inc. against peers pursuing similar technology classes.
Who files at Flexuspine's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Fleetwood Group
Fleetwood Group, Inc.
6 patents
- Flex-cable
Flex-Cable
6 patents
- Flexigo
FlexiGO INC.
6 patents
- Flexicare (Group)
Flexicare (Group) Limited
6 patents
- Flo
Flo, LLC
6 patents
- Floranova
Floranova Ltd.
6 patents
- Florelle
Florelle, Inc.
6 patents
- Floway
Floway, Inc.
6 patents
- Flexuspine ◀
Flexuspine Inc.
6 patents
What this shows Flexuspine holds 6 patents at rank #40,284, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Flexuspine
By rank, the assignees closest to #40,284 in granted patent volume.
Leaders in A61F (Filters Implantable INTO Blood Vessels)
Other assignees with the most granted patents in Flexuspine's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- Depuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- COOK Medical Technologies Llc 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien Lp 528 in class
Flexuspine's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 56% higher than 44% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 50.0% |
| 2016 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
Which technologies does Flexuspine Inc. patent most?
Top 2 of 2 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Specialized
Claim Depth Complex
Velocity Declining
Frequently Asked Questions
How many patents does Flexuspine Inc. hold?
Flexuspine Inc. holds 6 US granted patents filed between 2015 and 2022, spanning 2 technology areas.
What is Flexuspine Inc.'s Innovation Score?
Flexuspine Inc. has an Innovation Score of 33.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Flexuspine Inc. focus on?
Flexuspine Inc.'s top technology area is A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS) with 6 patents. The company has filed patents in 2 CPC subclasses total.
Is Flexuspine Inc.'s patent filing rate increasing or decreasing?
Flexuspine Inc.'s recent filing velocity is -80% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Flexuspine Inc.'s patents?
Flexuspine Inc.'s patents average 28.3 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Flexuspine Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Flexuspine's 6 grants land it in the top 56% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Flexuspine ranks #40,284 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61F - see who else leads that technology area. A61F leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.